3DP Technology and life-saving drugs combine to deliver significant quality-of-life benefits for rare disease patients CINCINNATI & CAMBRIDGE, England--(BUSINESS WIRE)--Aprecia Pharmaceuticals, LLC ...
Aprecia Pharmaceuticals Company, Inc. is specializing in 3D printed prescription medicine. It announced today a completed $35 million preferred stock financing led by Deerfield Management Company LP, ...
WEST LAFAYETTE, Ind. and CINCINNATI, Ohio — Health care is poised for a potential giant leap forward thanks to the 3D printing of medications. To advance the technology and science of 3D ...
CINCINNATI, March 8, 2022 /PRNewswire/ -- Aprecia Pharmaceuticals announced today that it has hired Garry Hedgepeth as Vice President of Quality. Mr. Hedgepeth's primary responsibility will be to ...
CINCINNATI, Nov. 15, 2023 /PRNewswire/ -- Aprecia, a precision drug delivery company, has partnered with the research and development experts at Battelle to develop groundbreaking 3D printing ...
CINCINNATI, Jan. 30, 2020 /PRNewswire/ -- Aprecia, the 3DP Pharmaceutical Company, announced today that Amol Matharu, Ph.D., has been named the company's Chief Scientific Officer. Matharu will lead ...
LANGHORNE, Pa., Jan. 27, 2016 /PRNewswire/ -- Aprecia Pharmaceuticals Company, Inc., an emerging pharmaceutical company specializing in three-dimensionally printed (3DP) prescription medicine, today ...
The active drug, levetiracetam, isn't new, but FDA approval of Spritam to treat certain forms of epilepsy guaranteed a spot in biopharma history for Aprecia Pharmaceuticals Co., which became the first ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Aprecia Pharmaceuticals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results